Mi Sun Won

MARKER FOR PROGNOSIS OF DIFFUSE TYPE GASTRIC CANCER AND TREATMENT TARGET

COMPOSITION COMPRISING VGLL1 PEPTIDE FOR TREATMENT OF CANCER

CELL-PENETRATING PEPTIDE, ANTI-CANCER PEPTIDE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME

DISUBSTITUTED ADAMANTYL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION FOR SUPPRESSING CANCER GROWTH COMPRISING SAME AS ACTIVE INGREDIENT

METHOD FOR PREVENTING OR TREATING CANCER USING SYT11 INHIBITOR

NOVEL COMPOUND HAVING MALATE DEHYDROGENASE INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT

ARYLOXY PHENOXY ACRYLIC COMPOUND HAVING HIF-1 INHIBITION ACTIVITY, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS AN ACTIVE INGREDIENT

Pharmaceutical composition for preventing and treating cancer, containing CYB5R3 gene or protein as active ingredient

Compounds as HIF-1α inhibitors and manufacturing process thereof

Disubstituted adamantyl derivative or pharmaceutically acceptable salt thereof, production method for same, and pharmaceutical composition for suppressing cancer metastasis comprising same as active ingredient

Compounds as HIF-1alphainhibitors and manufacturing process thereof

Aryloxy phenoxy acrylic compound having HIF-1 inhibition activity, method for preparing same, and pharmaceutical composition containing same as an active ingredient

G protein coupled receptor protein and use thereof

Biomarkers Indicative of Colon Cancer and Metastasis and Diagnosis and Screening Therapeutics Using the Same

Genome-wide construction of heterozygous deletion mutants containing gene-specific barcodes by the methods of 4-round serial or block PCR, or total gene synthesis thereof

Characterization of ESM-1 as a tumor associated marker of colorectal cancer